In such extensive studies, statins—which inhibit GPx4 biosynthesis—were shown to decrease tumor cell resistance to cytotoxic antitumor drugs by synergizing with GPx4 inhibitors such as RSL3 [185]. The gene discussed is GPX4; the disease is neoplasm.